AS012 / Sun Pharma - LARVOL DELTA

Efficacy and Safety of AS012 in Subjects With Non-segmental Vitiligo (clinicaltrials.gov) - P2 | N=327 | Completed | Sponsor: Sun Pharmaceutical Industries Limited | Active, not recruiting ➔ Completed

Trial completion • Dermatology • Vitiligo

Efficacy and Safety of AS012 in Subjects With Non-segmental Vitiligo (clinicaltrials.gov) - P2 | N=327 | Active, not recruiting | Sponsor: Sun Pharmaceutical Industries Limited | Recruiting ➔ Active, not recruiting | Trial completion date: May 2023 ➔ Jan 2023

Enrollment closed • Trial completion date • Dermatology • Vitiligo